ABSTRACT Despite multimodal treatment, glioblastoma (GBM) remains difficult to control because of diffuse invasion, tumor heterogeneity, immune dysfunction, and frequent recurrence. Increasing attention has focused on whether intestinal microbial communities and their products can modify systemic and central nervous sy...
T. AlRamadneh, R. Jyothi S., Priya Priyadarshini-Nayak et al.· MicrobiologyOpen· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.